Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SITAGLIPTIN; METFORMIN HYDROCHLORIDE

SITAGLIPTIN; METFORMIN HYDROCHLORIDE

Standard Dose
50MG; 500MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview SITAGLIPTIN; METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 202426 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient SITAGLIPTIN; METFORMIN HYDROCHLORIDE Form and strength TABLET; ORAL - 50MG; 500MG Sponsor APOTEX INC Submission history Latest submission status date: 2014-03-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview SITAGLIPTIN; METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 202426 (ANDA). Marketing status: None (Tentative Approval) Active ingredient SITAGLIPTIN; METFORMIN HYDROCHLORIDE Form and strength TABLET; ORAL - 50MG; 500MG Sponsor APOTEX INC Submission history Latest submission status date: 2014-03-10 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.
SITAGLIPTIN; METFORMIN HYDROCHLORIDE (SITAGLIPTIN; METFORMIN HYDROCHLORIDE) | Drug Monograph | MedicHelpline